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INTRODUCTION
METHODS
The Coronavirus disease 2019 (COVID-19) pandemic 
emerged in early 2020 and significantly altered the 
landscape of healthcare delivery. As of January 2021, 
more than 24 million cases and over 400,000 deaths 
have been reported in the United States alone. With the 
absence of a cure, treatment of hospitalized patients 
with COVID-19 has been particularly challenging. 
Physicians often treat hospitalized patients with COVID-
19 infection empirically with broad spectrum antibiotics 
on admission due to concerns of missing an underlying 
and treatable co-infection. In this study we aim to 
determine the rate of co-infections in hospitalized 







We conducted a retrospective study which included all 
patients who had a nasopharyngeal swab sample 
positive for SARS-CoV-2 infection at the Detroit Medical 
Center during April 2020. Out of 409 patients with SARS-
CoV-2 infection detected by the Cepheid Real-Time 
Polymerase Chain Reaction (RT-PCT) test, 390 had 
sputum or blood cultures ordered during their 
hospitalization. The results of each culture were 
examined, and the isolated organisms and date of the 
culture positivity were documented. Negative cultures 
and those showing normal flora or potential 
contaminants were merged into the negative category. 
Moreover, we analyzed results of non-culture tests such 
as urine legionella antigen, urine pneumococcal antigen, 
and influenza A and B PCR. 
DISCUSSION
Based on our findings, respiratory co-infections appear 
to be uncommon on initial presentation to the hospital in 
patients with COVID-19 infections. Secondary 
respiratory infections during hospitalization are more 
common (median 11 days to positive respiratory culture). 
Although only 10% of the total blood cultures obtained 
during hospitalization returned positive, around 70% of 
those (21 out of 30) were positive on admission. Based 
on our data, urine pneumococcal and urine legionella 
antigens appear to have no role in the evaluation of 
secondary bacterial infections in patients with SARS-
CoV-2 infection. A larger sample size is needed to 
determine the predictors of positive blood or respiratory 
cultures within 3 days of admission to the hospital to 
better guide management. Recent literature showing a 
paucity of secondary infections in patients admitted with 
SARS-CoV-2 support our conclusions.
Community acquired co-infections in patients 
hospitalized with SARS-CoV-2 appear to be uncommon 
based on our study. When a co-infection is suspected in 
critically ill patients, physicians should obtain respiratory 
and blood cultures before initiating empiric therapy. 
Empiric antibiotic therapy on admission does not appear 
to be warranted in the majority of patients.
Cultures Obtained During Hospitalization *
Positive blood or respiratory culture; N (%) 68/390 (17)
Positive blood culture; N (%) 30/296 (10)
Positive respiratory culture; N (%) 38/94 (40)
Days between admission and positive respiratory culture; 
Median (range)
11 (1-39)
Number of positive respiratory cultures within 3 days of 
admission
12 (31)
Days between admission and positive blood culture; Mean 
(range)
1 (1–45)
Number of positive blood cultures within 3 days of admission 21 (70)
Non-Culture Testing 
Urine legionella antigen; N (%) 0/126 (0)
Urine pneumococcal antigen; N (%) 4/125 (3.1)
Influenza A or B PCR; N (%) 0/221 (0)
Most Commonly Isolated Organisms ^
Respiratory cultures Total N = 61 
Staphylococcus aureus; N (%) 18 (29)
Klebsiella pneumoniae; N (%) 10 (16)
Pseudomonas aeruginosa; N (%) 10 (16)
Proteus mirabilis; N (%) 6 (9)
Acinetobacter baumanii; N (%) 4 (6.5)
Aspergillus spp.; N (%) 3 (5)
Other; N (%) 10 (16)
Blood cultures Total N = 36
Staphylococcus aureus; N (%) 4 (11)
Klebsiella pneumoniae; N (%) 4 (11)
Candida spp; N (%) 7 (19)
Proteus mirabilis; N (%) 2 (5)
Pseudomonas aeruginosa; N (%) 3 (8)
Other; N (%) 16 (44)
* Patients with no cultures obtained were excluded. Negative cultures or cultures deemed 
as contaminants or normal flora were merged into the negative category
^ Some patients had more than 1 organism isolated at the same time or at different times 
during the admission; Total N = total number of isolated organisms 
